Drugs & Targets FDA grants priority review to Enhertu in previously treated HER2-mutant metastatic NSCLC April 22, 2022Vol.48 No.16
In Brief Robert Vonderheide re-appointed director of Abramson Cancer Center April 15, 2022Vol.48 No.15
In Brief Charles Rogers, Razelle Kurzrock, Xue-Zhong Yu named to leadership roles at Medical College of Wisconsin April 15, 2022Vol.48 No.15
In Brief Cancer Study Group, Fox Chase establish collaborative patient care effort April 15, 2022Vol.48 No.15
Funding Opportunities DoD Melanoma Research Program anticipated funding opportunities for FY22 April 15, 2022Vol.48 No.15